LXRP - Lexaria Bioscience Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2018-08-30
2017-08-30
2016-08-30
Total Revenue
194
433
64
41
Cost of Revenue
11
25
30
46
Gross Profit
183
408
34
-5
Operating Expenses
Research Development
608
493
54
9
Selling General and Administrative
3,803
6,513
1,842
1,197
Total Operating Expenses
4,446
7,008
1,895
1,211
Operating Income or Loss
-4,263
-6,600
-1,861
-1,216
Interest Expense
-
0
6
2
Total Other Income/Expenses Net
-6
-9
-62
-59
Income Before Tax
-4,270
-6,609
-1,929
-1,277
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-4,270
-6,609
-1,929
-1,277
Net Income
-4,238
-6,599
-1,869
-1,215
Net Income available to common shareholders
-4,238
-6,599
-1,869
-1,215
Reported EPS
Basic
-
-0.09
-0.03
-0.03
Diluted
-
-0.09
-0.03
-0.03
Weighted average shares outstanding
Basic
-
70,960
58,766
43,840
Diluted
-
70,960
58,766
43,840
EBITDA
-
-6,607
-1,922
-1,274